CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
about
Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian AmazonHTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy.HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous SystemHuman T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.Inflammatory manifestations of HTLV-1 and their therapeutic options.Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada.HTLV-1-associated myelopathy/tropical spastic paraparesis.CXCL9 concentrations in cerebrospinal fluid and serum of patients with tick-borne encephalitis.Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing
P2860
Q33717705-24E20610-C60C-4E0A-A802-9F65334A3FA7Q33944201-FF19F1A5-5451-4DC4-B9AD-E4C5B508B35DQ34339734-36058465-E777-48B7-B25C-A5575B966942Q36156395-5E795752-4C05-4C33-9F49-11E136FE0D53Q36736791-3E38AB10-6F8B-4DC7-BAF5-0902B61F74E3Q37646610-6B02802A-9B34-4E71-92F9-6FA682967DE9Q38262169-AA5175E3-DC3A-4E15-9F07-9275EFF470B4Q38940579-78DEF264-334B-4230-A865-F0CBB8F913EBQ42426735-31621906-5546-4CA4-8F57-09C8550AE070Q45096240-7389EFEF-61EE-4E61-B4F6-09376420C2B8Q52723416-B577E45F-B7F0-4058-85E6-55D5D2817EE7Q58691752-17CD6AE3-13A0-432D-B6B7-20C39FA568A5
P2860
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@ast
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@en
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@nl
type
label
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@ast
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@en
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@nl
prefLabel
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@ast
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@en
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@nl
P2093
P2860
P921
P1476
CSF CXCL10, CXCL9, and neopter ...... y/tropical spastic paraparesis
@en
P2093
Ariella Coler-Reilly
Atae Utsunomiya
Eisuke Inoue
Hitoshi Ando
Junji Yamauchi
Kusuki Nishioka
Naoko Yagishita
Natsumi Araya
Shuji Izumo
Steven Jacobson
P2860
P356
10.1371/JOURNAL.PNTD.0002479
P407
P577
2013-01-01T00:00:00Z